dispersion and solvent for concentrate for dispersion for infusion.

DRUG2 trials

Sponsors

Grupo Espanol De Investigacion En Cancer De Mama, Unicancer

Conditions

Patients with invasive breast cancer in early stagesoestrogen-receptor (ER)-positive HER2-negative breast carcinoma

Phase 3

GERICO11_Adjuvant systemic treatment for oestrogen-receptor (ER)-positive HER2-negative breast carcinoma in women over 70 according to Genomic Grade (GG): chemotherapy + endocrine treatment versus endocrine treatment. A French UNICANCER Geriatric Oncology Group (GERICO) and Breast Group (UCBG) multicentre phase III trial

Active, not recruitingCTIS2024-516996-34-00

Unicanceroestrogen-receptor (ER)-positive HER2-negative breast carcinoma

Start: 2012-04-12Target: 1989Updated: 2024-10-31

Phase 4

LONG-TERM FOLLOW-UP STUDY OF EARLY STAGE BREAST CANCER PATIENTS INCLUDED IN GEICAM STUDIES

RecruitingCTIS2022-502706-33-00

Grupo Espanol De Investigacion En Cancer De MamaPatients with invasive breast cancer in early stages

Start: 2018-01-10Target: 8000Updated: 2025-07-16